Insights
Elevance Q2 2026 Earnings Call Insight
Elevance Q2 2026 earnings beat estimates by 20%, yet shares fell 8.54% as Medicaid concerns dominated the call. Get the full HealthWorks AI breakdown.
July 16, 2026
Analysis, playbooks, and research for government-sponsored health plans navigating a faster, more competitive market.
Elevance Q2 2026 earnings beat estimates by 20%, yet shares fell 8.54% as Medicaid concerns dominated the call. Get the full HealthWorks AI breakdown.
Network adequacy is no longer a competitive position in Medicare Advantage. Here is how leading health plans are moving from compliance to sculpting ahead of 2027 bids.
Seven of the largest MA payers reported Q1 2026. Read across the calls and the message is unambiguous. Here is what each one signaled, what they said collectively, and what it means for your AEP 2027 positioning
CVS Health’s Q1 2026 results delivered the clearest Aetna recovery signal the company has posted in two years.
Alignment’s Q1 2026 numbers tell a different story than the rest of the industry. Membership grew 30.9% to 284,800. Adjusted EBITDA grew 87.6% to $37.9 million. Both came in above the company’s own guidance.
The most surprising finding in Elevance Health’s Q1 2026 report is not the 16% adjusted EPS beat—it is the hidden anatomy of that beat. Of the $12.58 adjusted EPS.
The healthcare payer industry is changing rapidly—and our resources help you stay on top of it all. Sign up to get new insights, success stories, and more, sent right to your inbox.